BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 65%* for Small Cap Pro

1 year 40%, 2 years 50% and *3 years 65%

*Across 3 years $2158.56 only $755.50

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,998.74
      -0.38%
      US Tech 100
      20,219.20
      -0.75%
      Dow Jones
      44,722.06
      -0.31%
      Brent Oil
      72.395
      0.00%
      Bitcoin
      96,029.36
      0.06%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Mangoceuticals Inc (MGRX)

      7. Mangoceuticals Inc (MGRX) Financials

      Mangoceuticals Inc

      Mangoceuticals Inc (MGRX)

      NASDAQ
      2.53
      0.0451
      (1.81%)
      At close: November 27 4:00PM
      Delayed by 15 minutes
      2.5987
      0.0687
      ( 2.72% )
      After Hours: 5:43PM
      Delayed by 15 minutes

      Mangoceuticals Inc Financial Summary

      The current MGRX market cap is 6.24M. The company's latest EPS is USD -3.8383 and P/E is -0.66.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)
      Total Revenue 141k245k244k214k163k
      Operating Income -2.29M-1.8M-2.57M-2.37M-2.17M
      Net Income -2.28M-1.8M-2.57M-2.37M-2.39M
      Year End December 30 2023 202120222023
      USD ($)USD ($)USD ($)
      Total Revenue 09k731k
      Operating Income -18k-1.99M-9.22M
      Net Income -18k-2M-9.21M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)
      Total Assets 3.3M1.6M1.05M301k15.24M
      Total Liabilities 294k241k276k1.26M1.41M
      Total Equity 3M1.36M775k-958k13.83M
      Year End December 30 2023 202120222023
      USD ($)USD ($)USD ($)
      Total Assets 23k1M1.05M
      Total Liabilities 40k389k276k
      Total Equity -17k614k775k

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)
      Operating -3.59M-5.3M-7M-991k-2.57M
      Investing -4k-4k-4k N/A 65k
      Financing 5.86M5.86M7.06M267k2.26M
      Year End December 30 2023 202120222023
      USD ($)USD ($)USD ($)
      Operating -18k-1.35M-7M
      Investing N/A -43k-4k
      Financing 41k2.05M7.06M

      Stats and Ratios

      Market Cap 6.24M
      Price to Earnings Ratio -0.66
      Price to Sales Ratio 8.31
      Price to Cash Ratio 8.22
      Price to Book Ratio 7.83
      Dividend Yield -

      Share Statistics

      Shares Outstanding 2.4M
      Average Volume (1 week) 100.69k
      Average Volume (1 Month) 82.04k
      52 Week Change -68.50%
      52 Week High 16.80
      52 Week Low 2.10
      Spread (Intraday) 0.07 (2.72%)

      Company Info

      Company Name Mangoceuticals Inc
      Address 15110 n. dallas parkway, suite 600
      dallas, texas 75248
      Website https://www.mangorx.com
      Industry health & allied services,nec (8099)